Urge Congress to Act Boldly and Prioritize Cancer Research Funding

Urge Congress to act boldly and continue investing in Americans by supporting critical cancer research funding. By sending this message to your elected officials, you're standing tall in the fight to end pancreatic cancer — and ensuring Congress knows you're ready to make cancer research a national priority!

  1. Review the message below.
  2. Complete the form fields with your voting address information.
  3. Click the Send Message button to send your letter to these decision makers:
    • Targeted recipients based on your address

Contact

*Required fields
  By signing up, you will receive periodic updates and communications from the Pancreatic Cancer Action Network.
 

If you take action and have not already registered, you will receive periodic updates and communications from Pancreatic Cancer Action Network.

Message

Act Boldly to Rewrite the Future of Pancreatic Cancer

Dear [Decision Maker],

As your constituent and a supporter of the Pancreatic Cancer Action Network, I am writing to ask you to act boldly and reject the proposed cuts to the National Institutes of Health (NIH) in the administration's FY18 budget.

Less than two months ago, Congress approved a $2 billion increase for NIH - for the second year in a row. These back-to-back increases are critical for saving lives. This year, more than 53,000 Americans will be diagnosed with pancreatic cancer -- the deadliest major cancer with a 5-year survival rate of just 9 percent. The fact that the disease has surpassed breast cancer to become the third leading cause of cancer-related death and is expected to become the second by 2020, only underscores the urgency of continuing the down payment Congress has made on NIH and National Cancer Institute (NCI) funding.

I urge you to continue funding lifesaving cancer research by:
o Supporting $36.2 billion for NIH in FY2018, including $6 billion for the NCI and the funding provided from the 21st Century Cures Act.
o Continuing to include pancreatic cancer in the Department of Defense's Peer Review Cancer Research Program (PRCRP) and provide a funding increase for the program above FY2017 level.

Current and future pancreatic cancer patients are counting on you to stand with them at this critical time.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]